NCT00640445

Brief Summary

Veterans returning from combat deployments face the interrelated challenges of processing their combat experiences and transitioning back to civilian life. Unfortunately, many veterans wait years or decades before seeking help for post-deployment problems, if they seek it at all. This study seeks to determine whether Internet-Based Expressive Writing (IB-EW), a brief, low-cost, easily disseminated, and resource-efficient intervention, can reduce psychological symptoms and improve functioning among Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) veterans as they navigate this transition, while also attempting to reduce barriers to help-seeking. Expressive Writing, a highly private, readily accessible, and non-stigmatizing intervention, has a strong evidence-base in civilian populations, but its efficacy in combat veterans has not been tested. This study therefore seeks to test the efficacy of Expressive Writing in a veteran population while further enhancing its accessibility by delivering it over the internet (Internet-Based Expressive Writing; IB-EW). This study will comprise a randomized controlled trial with three conditions: (a) Internet-Based Expressive Writing, (b) Internet-Based Control Writing, and (c) No Writing/Treatment As Usual, with a total of 1152 OIF/OEF veterans randomized across these groups. Expressive Writing participants will write with feeling about their transition from being a soldier to being a civilian; Control Writing participants will write factually about the information needs of new veterans; and Treatment as Usual participants will complete the assessments but not engage in any writing assignments. Participants will complete standardized self-report measures of psychological symptoms, psychosocial functioning, and life satisfaction at baseline (Session 1) and at three months (Session 6) and six months (Session 7) post-intervention. Participants in writing conditions will write for 20 minutes on four consecutive days (Sessions 2-5) following completion of baseline measures (participants in the TAU condition will not complete Sessions 2-5). The study will also attempt to identify individual difference characteristics related to the efficacy of the treatment, to see who may be most likely to benefit from the treatment. Analyses will primarily entail multivariate analyses of variance. Power is adequate to detect even a small effect.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,292

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jun 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 21, 2008

Completed
3.2 years until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

September 23, 2015

Status Verified

September 1, 2015

Enrollment Period

1.8 years

First QC Date

March 18, 2008

Last Update Submit

September 21, 2015

Conditions

Keywords

Clinical TrialCombat DisordersPTSDInternet-Based InterventionMental Health ServicesPost-deployment Reintegration

Outcome Measures

Primary Outcomes (7)

  • PTSD symptoms

    Baseline, 3-month, 6-month

  • Hostility

    Baseline, 3-month, 6-month

  • Psychological distress

    Baseline, 3-month, 6-month

  • Physical symptoms

    Baseline, 3-month, 6-month

  • Reintegration difficulty

    Baseline, 3-month, 6-month

  • Social support

    Baseline, 3-month, 6-month

  • Life satisfaction

    Baseline, 3-month, 6-month

Secondary Outcomes (2)

  • Emotion and causal word use in participants' essays

    Intervention Sessions (up to 4 sessions post-baseline for participants assigned to a writing condition)

  • Employment status

    Baseline, 3-month, 6-month

Study Arms (3)

Expressive Writing

EXPERIMENTAL

Participants assigned to the Expressive Writing (EW) condition will write about their deepest thoughts and feelings associated with their experience transitioning from being a soldier to being a civilian for 20 minutes a day for 4 days within a week.

Behavioral: Expressive Writing

Control Writing

ACTIVE COMPARATOR

Those assigned to control writing condition will write factually about the information needs of veterans transitioning from active duty to civilian status for 20 minutes on 4 days within one week.

Behavioral: Control Writing

No Writing Control

NO INTERVENTION

Treatment As Usual

Interventions

In EW, people are asked to write about their deepest thoughts and feelings surrounding a significant life event for 20 minutes a day for 4 days

Expressive Writing
Control WritingBEHAVIORAL

Those assigned to control writing conditions are asked to describe factual information for 20 minutes a day for 4 days.

Control Writing

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran from current wars in Iraq and Afghanistan
  • At least a little difficulty transitioning from soldier to civilian
  • Access to computer with internet
  • Provide valid contact information
  • Available to participate for up to 40 minutes per session
  • Interested in participation
  • Understand procedures and consent
  • Note: participants are recruited by random selection from the target population

You may not qualify if:

  • Severe depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Medical Center

Minneapolis, Minnesota, 55417, United States

Location

Related Publications (1)

  • Sayer NA, Orazem RJ, Noorbaloochi S, Gravely A, Frazier P, Carlson KF, Schnurr PP, Oleson H. Iraq and Afghanistan War Veterans with Reintegration Problems: Differences by Veterans Affairs Healthcare User Status. Adm Policy Ment Health. 2015 Jul;42(4):493-503. doi: 10.1007/s10488-014-0564-2.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticCombat Disorders

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Nina A Sayer, PhD

    Minneapolis Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director, CCDOR; Research Director, PTBRI QUERI

Study Record Dates

First Submitted

March 18, 2008

First Posted

March 21, 2008

Study Start

June 1, 2011

Primary Completion

April 1, 2013

Study Completion

September 1, 2013

Last Updated

September 23, 2015

Record last verified: 2015-09

Locations